This breakfast briefing will examine the importance of Artificial Intelligence in accelerating drug development and drug discovery. The speakers will share their succss stories and practical case examples of how they have harnessed machine learning to ‘go faster’ and shorten the development and testing phase from 3-5 years to 1 year.
Places are strictly limited and on a first come first served basis only so make sure you reserve your place right away!
DATE AND TIME
Fri 1 June 2018
08:00 – 10:00 CDT
110 E. 23rd St.
Chicago, Ilinois 60616
The Importance of Accelerating Drug Development & Drug Discovery: Examining Successful Case Studies
- How can AI and ML reduce the drug development cycle
- Utilizing AI for innovation in R&D and drug delivery
- Creating new mechanisms and pathways
- Practical uses of data analysis and deep learning in oncology
- Cost benefit analysis
Spyro Mousses, CEO, Systems Oncology
John Baldoni Ph.D., Senior Vice President, DPU Head, ln Silico Discovery, GSK Pharmaceuticals
Chris Yoo, CEO, Systems Imagination
Monica Martin de Bustamante, Managing Director, CBPartners
08:00 – 08:30 Arrival, Coffee & Networking
08:30 – 08:40 Welcome and Introduction
08:40 – 09:20 Panel Discussion & Case Study Presentation
09:20 – 09:35 General Q&A
09:35 – 09:40 Summary & Close
09:40 – 10:00 Networking & Coffee
Breakfast pastries, coffee and various refreshments will be available.
We hope you can make it to the upcoming Breakfast Briefing taking place in June in Chicago!